V

Verastem
D

VSTM

6.14000
USD
0.85
(15.96%)
مغلق
حجم التداول
224,206
الربح لكل سهم
-3
العائد الربحي
-
P/E
-2
حجم السوق
337,387,904
أصول ذات صلة
A
ARRY
0.22500
(3.37%)
6.90000 USD
C
CRSP
-1.350
(-2.04%)
64.760 USD
E
EXEL
0.790
(1.76%)
45.600 USD
INCY
INCY
-0.300
(-0.43%)
70.180 USD
المزيد
الأخبار المقالات

العنوان: Verastem

القطاع: Healthcare
الصناعة: Biotechnology
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer thatpromote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.